Dan-Ning Hu1, Mingchao Bi1, David Y Zhang2, Fei Ye2, Steven A McCormick3, Chi-Chao Chan4. 1. Tissue Culture Center, New York Eye and Ear Infirmary at Mount Sinai Health Center, New York, New York, United States. 2. Department of Pathology, Mount Sinai Hospital, New York, New York, United States. 3. Department of Pathology, New York Eye and Ear Infirmary at Mount Sinai Health Center, New York, New York, United States Department of Ophthalmology, New York Eye and Ear Infirmary at Mount Sinai Health Center, New York, New York, United States; New York Medical College, Valhalla, New York, United States. 4. Immunopathology Section, Laboratory of Immunology, National Eye Institute, Bethesda, Maryland, United States.
Abstract
PURPOSE: Melanocytes are one of the major cellular components in the uvea. Interleukin-8/CXCL8 and monocyte chemoattractant protein-1 (MCP-1/CCL2) are the two most important proinflammatory chemokines. We studied the constitutive and lipopolysaccharide (LPS)-induced expression of IL-8 and MCP-1 in cultured human uveal melanocytes (UM) and explored the relevant signal pathways. METHODS: Conditioned media and cells were collected from UM cultured in medium with and without stimulation of LPS. Interleukin-8 and MCP-1 proteins and mRNAs were measured using an ELISA kit and RT-PCR, respectively. Nuclear factor (NF)-κB in nuclear extracts and phosphorylated p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinases1/2 (ERK1/2), and c-Jun N-terminal kinase1/2 (JNK1/2) in cells cultured with and without LPS were measured by ELISA kits. Inhibitors of p38 (SB203580), ERK1/2 (UO1026), JNK1/2 (SP600125), and NF-κB (BAY11-7082) were added to the cultures to evaluate their effects. RESULTS: Low levels of IL-8 and MCP-1 proteins were detected in the conditioned media in UM cultured without serum. Lipopolysaccharide (0.01-1 μg/mL) increased IL-8 and MCP-1 mRNAs and proteins levels in a dose- and time-dependent manner, accompanied by a significant increase of phosphorylated JNK1/2 in cell lysates and NF-κB in nuclear extracts. Nuclear factor-κB and JNK1/2 inhibitors significantly blocked LPS-induced expression of IL-8 and MCP-1. CONCLUSIONS: This is the first report on the expression and secretion of chemokines by UM. The data suggest that UM may play a role in the pathogenesis of ocular inflammatory diseases. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE: Melanocytes are one of the major cellular components in the uvea. Interleukin-8/CXCL8 and monocyte chemoattractant protein-1 (MCP-1/CCL2) are the two most important proinflammatory chemokines. We studied the constitutive and lipopolysaccharide (LPS)-induced expression of IL-8 and MCP-1 in cultured human uveal melanocytes (UM) and explored the relevant signal pathways. METHODS: Conditioned media and cells were collected from UM cultured in medium with and without stimulation of LPS. Interleukin-8 and MCP-1 proteins and mRNAs were measured using an ELISA kit and RT-PCR, respectively. Nuclear factor (NF)-κB in nuclear extracts and phosphorylated p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinases1/2 (ERK1/2), and c-Jun N-terminal kinase1/2 (JNK1/2) in cells cultured with and without LPS were measured by ELISA kits. Inhibitors of p38 (SB203580), ERK1/2 (UO1026), JNK1/2 (SP600125), and NF-κB (BAY11-7082) were added to the cultures to evaluate their effects. RESULTS: Low levels of IL-8 and MCP-1 proteins were detected in the conditioned media in UM cultured without serum. Lipopolysaccharide (0.01-1 μg/mL) increased IL-8 and MCP-1 mRNAs and proteins levels in a dose- and time-dependent manner, accompanied by a significant increase of phosphorylated JNK1/2 in cell lysates and NF-κB in nuclear extracts. Nuclear factor-κB and JNK1/2 inhibitors significantly blocked LPS-induced expression of IL-8 and MCP-1. CONCLUSIONS: This is the first report on the expression and secretion of chemokines by UM. The data suggest that UM may play a role in the pathogenesis of ocular inflammatory diseases. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Authors: Ahmed M Abu El-Asrar; Saleh S Al-Obeidan; Dustan Kangave; Karel Geboes; Ghislain Opdenakker; Jo Van Damme; Sofie Struyf Journal: Immunobiology Date: 2011-04-07 Impact factor: 3.144
Authors: Dan-Ning Hu; Min Chen; David Y Zhang; Fei Ye; Steven A McCormick; Chi-Chao Chan Journal: Invest Ophthalmol Vis Sci Date: 2011-06-01 Impact factor: 4.799
Authors: Somnath Banerjee; Vijay Savant; Robert A H Scott; S John Curnow; Graham R Wallace; Philip I Murray Journal: Invest Ophthalmol Vis Sci Date: 2007-05 Impact factor: 4.799
Authors: Gareth T Higgins; Jiang Huai Wang; Peter Dockery; Philip E Cleary; H Paul Redmond Journal: Invest Ophthalmol Vis Sci Date: 2003-04 Impact factor: 4.799
Authors: Jin-Zhong Zhang; Megan E Cavet; Karl R VanderMeid; Mercedes Salvador-Silva; Francisco J López; Keith W Ward Journal: Mol Vis Date: 2009-12-08 Impact factor: 2.367
Authors: Ian R Reekie; Srilakshmi Sharma; Andrew Foers; Jonathan Sherlock; Mark C Coles; Andrew D Dick; Alastair K Denniston; Christopher D Buckley Journal: Front Med (Lausanne) Date: 2021-10-29